Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18416110 | 0.94 | KDM4E (0.41) | KDM4EATML3MBTL1ERBB2CYP1A2 | |
| SCHEMBL14848517 | 0.94 | KDM4E (0.45) | KDM4EATML3MBTL1MEN1ALDH1A1 | |
| SCHEMBL18416088 | 0.91 | KDM4E (0.39) | KDM4EATML3MBTL1ERBB2CYP1A2 | |
| SCHEMBL14848579 | 0.90 | KDM4E (0.43) | KDM4EATML3MBTL1ERBB2CYP1A2 | |
| SCHEMBL7248759 | 0.90 | L3MBTL1 (0.35) | KDM4EATML3MBTL1ERBB2CYP1A2 | |
| SCHEMBL18416098 | 0.89 | KDM4E (0.33) | KDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL18416099 | 0.89 | KDM4E (0.33) | KDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL20349159 | 0.89 | KDM4E (0.40) | KDM4EATML3MBTL1MEN1ALDH1A1 | |
| SCHEMBL16271369 | 0.87 | KDM4E (0.41) | KDM4EATML3MBTL1ERBB2CYP1A2 | |
| SCHEMBL15686433 | 0.87 | KDM4E (0.47) | KDM4EATML3MBTL1CYP1A2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170029362-A1 | LUMINESCENT COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY | 2017-02-02 | — | — | US | disclosed |
| US-20170029362-A1 | LUMINESCENT COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY | 2017-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170029362-A1 | LUMINESCENT COMPOUNDS | AHR, CCNL2, ARNT | KDM4E 1362/4885ATM 3365/4885L3MBTL1 615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.